Business intelligence reports for the lab diagnostics industry
Subscribe for Exclusive Access.
Subscriptions & Reports
![Mar2022-DTET-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/Mar2022-DTET-Cover.webp)
![March2022-LCA.Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LCA.Cover_.webp)
![March2022-LIR-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LIR-Cover.webp)
![April-2022-NLR-Briefing-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/April-2022-NLR-Briefing-Cover.webp)
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Leader in Brain Health Sector Achieves Key Certification
ST. LOUIS, MO — C2N Diagnostics has earned ISO 13485:2016 certification for its quality management system. In late 2020 C2N launched the PrecivityAD™ test, an innovative blood test intended for use with patients with cognitive impairment. The test aims to help...
Newly Identified Protein May Help Diagnose Ulcerative Colitis
An international research collaboration has discovered a potential new diagnostic marker for ulcerative colitis in a trans-ethnic analysis of Japanese and White patients. The finding could lead to the development of non-invasive, diagnostic blood test to both...
Blood-Based Test Uses Lipid Profiles to Detect Early-Stage Lung Cancer
Research team creates a promising new mass spectrometry-based blood lipid test.
MRI May Lower Breast Cancer Deaths from Variants in 3 Genes
Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more than 50 percent among women who carry certain genetic changes in three genes, according to a comparative modeling analysis published Feb. 17, 2022, in JAMA Oncology. The...
Financing to Advance Early Autism Diagnosis and Treatment in Children
ATLANTA, GA — (BUSINESS WIRE) — EarliTec Dx, Inc. (“EarliTec”), a digital health company developing novel diagnostic and therapeutic products for children with autism spectrum disorder (ASD) and early childhood vulnerabilities, announced today a $19.5 million...
COVID-19 Testing Company in Hot Water for Numerous Infractions
An Illinois-based COVID-19 testing company and its laboratory is facing lawsuits from two different states as well as investigations from several state and federal authorities after patient and employee complaints brought to light a number of problems. The Center...